Testosterone Cypionate Patent Expiration
Testosterone Cypionate was first introduced by Azurity Pharmaceuticals Inc
Testosterone Cypionate Patents
Given below is the list of patents protecting Testosterone Cypionate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Azmiro | US11311554 | Pharmaceutical compositions of testosterone | Mar 25, 2039 | Azurity |
| Azmiro | US11642355 | Pharmaceutical compositions of testosterone | Mar 25, 2039 | Azurity |
| Azmiro | US12138271 | Pharmaceutical compositions of testosterone | Mar 25, 2039 | Azurity |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Testosterone Cypionate's patents.
Latest Legal Activities on Testosterone Cypionate's Patents
Given below is the list recent legal activities going on the following patents of Testosterone Cypionate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 19 Jan, 2024 | US11642355 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 19 Jan, 2024 | US11311554 |
| Electronic Review Critical
| 09 May, 2023 | US11642355 |
| Patent eGrant Notification | 09 May, 2023 | US11642355 |
| Recordation of Patent eGrant | 09 May, 2023 | US11642355 |
| Mail Patent eGrant Notification | 09 May, 2023 | US11642355 |
| Recordation of Patent Grant Mailed Critical
| 09 May, 2023 | US11642355 |
| Patent Issue Date Used in PTA Calculation Critical
| 09 May, 2023 | US11642355 |
| Email Notification Critical
| 09 May, 2023 | US11642355 |
| Email Notification Critical
| 20 Apr, 2023 | US11642355 |
Testosterone Cypionate's Family Patents
